Aktie A2P4LJ PHARMASGP HOLDING SE
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen PharmaSGP Holding SE

Aktien

A2P4LJ

DE000A2P4LJ5

PSG

Markt geschlossen - Xetra
Andere Börsenplätze
 17:35:59 24.04.2024 		% 5 Tage % 1. Jan.
22,2 EUR +1,83 % Intraday Chart für PharmaSGP Holding SE +2,78 % -1,33 %
2023 PharmaSGP Holding SE meldet Ergebnis für die neun Monate bis zum 30. September 2023 CI
2023 PharmaSGP Holding SE meldet Ergebnis für das Halbjahr bis zum 30. Juni 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
AFR: PharmaSGP Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
PharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 2023
PharmaSGP Holding SE Proposes Dividend for the Financial Year 2023
PharmaSGP Holding SE Announces Changes to Dividend Policy
PharmaSGP exceeds the € 100 million revenues mark in 2023 and plans further profitable growth in 2024
PharmaSGP Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
PharmaSGP Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
PharmaSGP Holding SE Reports Earnings Results for the Nine Months Ended September 30, 2023
PharmaSGP continues the profitable growth course of the previous quarters in the third quarter of 2023
PharmaSGP Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
PharmaSGP Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Tranche Update on PharmaSGP Holding SE's Equity Buyback Plan announced on January 9, 2023.
PharmaSGP Holding SE Reports Earnings Results for the Half Year Ended June 30, 2023
AFR: PharmaSGP Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
PharmaSGP achieves top performance in the first half of 2023
PharmaSGP Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
PharmaSGP Completes EUR2 Million Share Buyback Program
CMS: PharmaSGP Holding SE completes Share Buy-Back Program
CMS: PharmaSGP Holding SE: Release of a capital market information
CMS: PharmaSGP Holding SE: Release of a capital market information
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2P4LJ Aktie
  4. Nachrichten PharmaSGP Holding SE
  5. Andere Sprachen